Absolute treatment effects of novel antidiabetic drugs on a composite renal outcome: meta-analysis of digitalized individual patient data.
Maximilian BrockmeyerClaudio ParcoKris Gregory VargasRalf WestenfeldChristian JungMalte KelmMichael RodenCihan AkbulutSabrina SchlesingerGeorg WolffOliver KussPublished in: Journal of nephrology (2024)
The present meta-analysis of digitalized individual patient data revealed moderate and similar absolute treatment benefits of GLP-1 receptor agonists and SGLT2 inhibitors compared to placebo for a composite renal outcome.